Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: A combined analysis of external evidence and clinical expertise

Mark Speakman,Jose E. Batista,Richard Berges,E. Chartier-Kastler,Giario Conti,F. Desgrandchamps,Kurt Dreikorn,Franklin C. Lowe,Michael P. O’Leary,M. Perez,J. Trachtenberg,Andrea Tubaro,B. Meesen,Louis Smets,H. Stoevelaar

Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: A combined analysis of external evidence and clinical expertise

2005

Mark Speakman
Jose E. Batista
Richard Berges
E. Chartier-Kastler
Giario Conti
F. Desgrandchamps
Kurt Dreikorn
Franklin C. Lowe
Michael P. O’Leary
M. Perez
J. Trachtenberg
Andrea Tubaro
B. Meesen
Louis Smets
H. Stoevelaar

Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertise

Keywords:

Urology
Evidence-based medicine
Hyperplasia
Disease
Medicine
Lower urinary tract symptoms
Pathology
disease progression
risk profile
Combination therapy
maximum flow rate
clinical expertise

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations